Original Article

Cefazolin versus Cefazolin plus Metronidazole for Antibiotic Prophylaxis at Cesarean Section

Authors: Norman L. Meyer, MD, PHD, Keehn V. Hosier, MD, Kim Scott, MD, Gary H. Lipscomb, MD

Abstract

Background Although prophylactic antibiotic medications have been shown to reduce the incidence of postoperative infectious morbidity after cesarean delivery, the most effective regimens have not been established. The purpose of this investigation was to compare the efficacy and costs of prophylaxis with cefazolin alone with cefazolin plus metronidazole. Methods Women undergoing cesarean delivery were randomized to prophylaxis with 2 g cefazolin (n = 81) or 1 g cefazolin plus 500 mg metronidazole (n = 79). Postoperative infectious morbidity and the duration of hospitalization in the two groups were compared. Results Thirty-seven (23%) of 160 patients developed endomyometritis. There was a significant reduction in the number of postoperative infections (14 versus 32%) and hospital days (3.12 versus 4.46) with cefazolin and metronidazole prophylaxis (P = 0.0064 versus P = 0.014) compared with cefazolin alone. The estimated antibiotic prophylaxis cost per person was less with cefazolin and metronidazole than with cefazolin alone ($9.12 versus $26.73). Conclusion Antibiotic prophylaxis with metronidazole and cefazolin results in fewer postoperative infections, decreased duration of hospitalization, and lower medication cost than cefazolin alone.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Anstey JT, Sheldon GW, Blythe JG. Infectious morbidity after primary cesarean sections in a private institution. Am J Obstet Gynecol 1980; 136: 205–210.
 
2. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev 2002; 3: CD000933.
 
3. Sweet RL, Gibbs RS. Infectious Diseases of the Female Genital Tract. Philadelphia, Lippincott Williams & Wilkins, 2002, ed 4.
 
4. ASHP Commission on Therapeutics. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Clin Pharm 1992; 11: 483–513.
 
5. Crombleholme WR. Use of prophylactic antibiotics in obstetrics and gynecology. Clin Obstet Gynecol 1988; 31: 466–472.
 
6. Jakobi P, Weissman A, Zimmer EZ, et al. Single-dose cefazolin prophylaxis for cesarean section. Am J Obstet Gynecol 1988; 158: 1049–1052.
 
7. Hopkins L, Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst Rev 2000; 2: CD001136.
 
8. Carlson C, Duff P. Antibiotic prophylaxis for cesarean delivery: Is an extended-spectrum agent necessary? Obstet Gynecol 1990; 76: 343–346.
 
9. Rivers TE. Considerations for surgical prophylaxis and perioperative antibiotic therapy, in Pharmacotherapeutics Update. Birmingham, AL, Baptist Medical Center Princeton, 1995, vol 10, p 6.
 
10. Faro S, Martens MG, Hammill HA, et al. Antibiotic prophylaxis: Is there a difference? Am J Obstet Gynecol 1990; 162: 900–909.
 
11. Rivers TE. Considerations in the treatment of anaerobic infections, in Pharmacotherapeutics Update. Birmingham, AL, Baptist Medical Center Princeton, 1991, vol 6, p 1.